When Experience Becomes Invisible: The Growing Problem of Commoditization in Aesthetic Medicine

One of the conversations I have increasingly often with experienced aesthetic clinicians is about how difficult it has become to differentiate genuine clinical expertise from good marketing.

These are clinicians who have spent years developing their skills, investing in advanced education, treating thousands of patients and learning, often through experience that cannot be taught in a classroom, how to assess a face, understand anatomy, manage complications, recognize when a treatment is inappropriate and, perhaps most importantly, when not to treat someone at all.

What frustrates them is watching the marketplace increasingly place those years of experience on the same playing field as someone who has completed an introductory Botox and filler course and decided to enter the aesthetic business.

That is not an argument against new clinicians. Every experienced provider was new at some point, and there has to be a pathway for clinicians to enter aesthetic medicine, learn and develop their skills.

The problem is that the consumer often has very little ability to tell the difference between someone who is beginning that journey and someone who has spent a significant portion of their career developing advanced expertise.

And that is where I think aesthetic medicine has a growing problem.

The word "certified" doesn't tell the whole story

There is a tremendous amount of comfort associated with the word "certified." To a consumer, it can sound like a meaningful indication of expertise. But certification or completion of a training program doesn't necessarily communicate where a clinician is in their development, how much hands-on experience they have or how much additional education they have pursued since that initial training.

There is an enormous difference between being trained to perform a procedure and developing the clinical judgment that comes from performing that procedure repeatedly, on different patients, with different anatomy, different expectations and different complications over many years.

That distinction can be difficult for the public to see.

If two clinicians are both advertising Botox and filler, both have professional credentials, both have attractive before-and-after photographs and both have an impressive social media presence, what tells a prospective patient that one may have ten years of aesthetic experience while the other may have been injecting for ten months?

For most consumers, there simply isn't enough information available to answer that question.

And when consumers cannot easily distinguish expertise, they naturally begin relying on the things they can see.

The branding.

The Instagram account.

The photographs.

The promotions.

The reviews.

The location.

And, increasingly, the price.

That is how a specialized medical service begins to move toward commoditization.

Aesthetic medicine is particularly vulnerable to commoditization

There is something unusual about aesthetics compared with many other areas of medicine. The results are highly visible, the procedures are heavily marketed and the products and devices themselves are often recognizable consumer brands.

A patient may walk into two different practices and receive what appears to be the same treatment using the same product.

That creates an understandable perception that the product or procedure is the primary thing being purchased.

But in reality, the product is only one part of the equation.

The expertise of the person assessing the patient, determining whether they are an appropriate candidate, selecting the treatment, deciding where and how much to use, understanding the interaction between different treatments and recognizing when the desired result is not clinically appropriate is an enormous part of the value.

The syringe may contain the same product.

The clinician does not.

This is where I believe the aesthetic industry has an opportunity to rethink how it communicates value.

We have become very good at marketing treatments and not nearly as good at marketing expertise

Scroll through aesthetic medicine on social media and you will see an extraordinary amount of attention devoted to the treatment itself.

Before and after photographs. Treatment names. Product names. Special offers. Memberships. Packages. Promotions.

What you see considerably less often is a meaningful explanation of the clinician's actual depth of experience.

How many years have they been practicing aesthetics?

How extensively have they studied facial anatomy?

What types of patients do they specialize in?

How much of their practice is devoted to aesthetics?

What advanced training have they pursued?

How do they approach complex cases?

How do they handle complications?

What happens when a patient asks for a treatment the clinician does not believe is appropriate?

Those questions tell a prospective patient far more about clinical expertise than whether a provider's Instagram feed has beautiful photography.

The American Society of Plastic Surgeons has similarly encouraged patients to investigate a provider's qualifications, training and experience rather than relying on marketing alone.

The difficulty is that the industry has not yet established particularly effective ways of communicating these differences to consumers.

The experienced clinician can end up competing on the wrong things

This is where I have considerable empathy for the clinicians who raise this issue with me.

Imagine spending ten or fifteen years developing your craft and building a reputation around your clinical judgment, only to find yourself competing for patients against someone whose primary differentiators are a beautiful website, aggressive social media marketing and a lower price.

It is incredibly difficult to compete on expertise when the marketplace has not taught the consumer how to recognize expertise.

And this is not simply a problem for individual clinicians.

It is a problem for the industry.

When consumers perceive providers as interchangeable, price becomes increasingly important. If the treatment is perceived as essentially the same regardless of who performs it, why wouldn't a patient choose the person offering it for less?

That creates pressure on experienced clinicians to discount their services, increase promotional activity or spend more heavily on patient acquisition, rather than continuing to invest in the thing that should arguably matter most: developing and demonstrating clinical excellence.

Differentiation has to go deeper than branding

There is nothing wrong with beautiful branding. There is nothing wrong with a strong social media presence. There is nothing wrong with being excellent at marketing.

In fact, a great aesthetic practice needs to be good at all of those things.

But branding should communicate expertise rather than substitute for it.

The most valuable differentiation in aesthetic medicine is not necessarily that a practice has a prettier logo, a more sophisticated Instagram feed or a better promotion.

It is that a patient can understand why the clinician behind the practice is different.

That might be years of experience. It might be a particular area of specialization. It might be advanced training. It might be an unusually strong understanding of facial anatomy. It might be an approach to natural-looking results that has been refined over thousands of patients.

Whatever it is, it needs to be visible.

Experienced clinicians sometimes assume that patients will recognize their expertise simply because they have been practicing for years. Unfortunately, that is not necessarily how the market works.

If the consumer cannot see the difference, the market cannot reliably price the difference.

That is an uncomfortable reality, but it is an important one.

New clinicians are not the enemy

I think it is important to say this clearly because this conversation can easily become unnecessarily divisive.

The issue is not that someone who is relatively new to aesthetic medicine should not be allowed to practice.

The issue is transparency.

A clinician who is beginning their aesthetic career should be able to build a practice and develop a reputation. But there should also be a meaningful distinction between being newly trained and being highly experienced.

Those aren't insults.

They are simply different stages of professional development.

The same principle applies in almost every profession. We don't expect someone who has just entered a field to have the same depth of experience as someone who has spent fifteen years mastering it. There is nothing demeaning about acknowledging that difference.

In fact, acknowledging it gives newer clinicians something valuable: a clear path to demonstrate their development over time.

The goal should not be to prevent new clinicians from entering aesthetic medicine. It should be to create a culture where continued education, mentorship, experience and clinical judgment are visibly valued.

Practices have a role to play too

This issue also extends beyond the individual provider.

Practices need to think carefully about what they are actually hiring when they recruit an aesthetic clinician.

If the job description essentially reduces the role to "must be able to inject Botox and filler," the practice is already treating the position as a commodity.

The technical ability to perform a procedure is important, but it is only one component of a successful aesthetic clinician.

The best providers I encounter bring an aesthetic eye, clinical judgment, communication skills, patient assessment skills, an understanding of anatomy and the confidence to tell a patient when their requested treatment isn't appropriate.

Those qualities are considerably harder to teach than a treatment protocol.

They are also considerably harder to replace.

From a recruiting perspective, this is one of the reasons I have always believed that simply searching for someone who checks a list of technical requirements isn't enough. A resume can tell you where someone has worked and what training they have completed. It doesn't necessarily tell you how they think clinically, how they interact with patients or what kind of aesthetic judgment they have developed.

That requires a much deeper level of evaluation.

We need to make expertise easier for patients to recognize

Ultimately, I think the answer is not less competition. It is better differentiation.

The aesthetic industry is going to continue to grow, and more clinicians are going to enter the space. More practices will open. More products and devices will be introduced. More businesses will compete for the same patients.

That is not going away.

What can change is the way we communicate the difference between providers.

We should be encouraging consumers to ask better questions about who is treating them rather than allowing "certified" to become a substitute for understanding experience.

We should be encouraging clinicians to talk openly about their education, their experience and their areas of expertise.

And we should be encouraging practices to recognize that the clinician they hire is not simply a person who performs a procedure. They are the person whose judgment ultimately represents the clinical reputation of the business.

Because aesthetic medicine is not really a commodity.

Botox is a product. Filler is a product. A laser is a device.

The clinical decision about what to do, what not to do and how to do it is where the expertise lies.

The industry will continue moving toward commoditization if we allow the treatment itself to become the product and the provider to become interchangeable.

The opportunity is to do the opposite.

Make the expertise visible.

When patients understand that there can be a meaningful difference between someone who has learned how to perform a treatment and someone who has spent years mastering the art and science behind it, the conversation changes.

And perhaps that is one of the most important conversations aesthetic medicine needs to have right now.